AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs

BOSTON--(BUSINESS WIRE)--AVS (Amplitude Vascular Systems, Inc), an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced the appointment of Elizabeth Galle as the company’s new Vice President of Clinical Affairs. She comes to AVS with more than two decades of leadership experience in the device space, most recently serving as the Vice President of Global Clinical Research at CVRx. “In a time of signifi